Equities research analysts at Wedbush upped their Q1 2025 earnings per share estimates for Beam Therapeutics in a research note issued on Monday, March 10th. Wedbush analyst D. Nierengarten now ...

Stacey Winter joined Wedbush Securities in 2002 and currently serves as managing director, head of equity sales and head of ...

Wedbush said Friday it expects North American box office to rise at least 7% in 2025, with double-digit growth from the ...

US equity indexes rose after midday trading on Friday amid a reduced risk of a government shutdown and President Donald Trump's "productive" discussions with Russian President Vladimir Putin on the ...

Wedbush raised the firm’s price target on Turtle Beach (TBCH) to $21 from $20 and keeps an Outperform rating on the shares. The firm notes that ...

Wedbush raised the firm’s price target on Rubrik (RBRK) to $80 from $75 and keeps an Outperform rating on the shares. The firm notes Rubrik ...

It’s been a bad month for the stock market. But it’s been a terrible month—in fact, a terrible year—for Tesla. Even after ...

Tesla's reported letter comes after unpredictable Trump trade policy moves that have unsettled businesses and markets.

US stocks slid Thursday and the S&P 500 closed in correction, down more than 10% from its record high in February, as ...

Various factors have weighed on tech stocks this year, including investor unease over Trump's tariffs and AI spending.

During a highly unusual showroom event, president Donald Trump gushed over Tesla's offerings. The stunt could end up hurting ...

Tesla’s stock began rising from the opening Tuesday after Trump posted overnight on his Truth Social platform that Musk was “putting it on the line” to help the country. Trump claimed in the post that ...